Well the market seems to be responding well to todays releases.
I thought announcements were a bit lacking however as Chebbbit has said no news is good new. Well I think it is better than no news, they have no road blocks or known issues pointed out by the FDA so one can only hope now it is just simply following the process to prove the product. So far the level of testing that RECCE has shown no antibiotic resistance with repeated use.
I know if it was my product I would test the hell out of it prior to FDA submission, even over and above what ever criteria was required. I normally like to push to the point where something would fail and re-run repeatedly to see if fail point is similar each time, at least I then know the true limitations of my product. I like to think that RECCE has done similar with this compound prior to FDA submission, making the approval process a formality and as economical as possible.
I'm looking forward to watching the pre-recorded interview prior to todays investors presentation.
Baldy
RCE Price at posting:
20.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)